Insider Cluster (3 insiders) ·Filed Jun 24, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 3 insiders, $0.2M total
Actionable Insight • Neutral

The insider sales are too small to carry informational content. Monitor for any larger insider transactions or changes in trading patterns, but this cluster alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
TWST ▲ +72.78% at T+60d
NEUTRAL call ✓ call won +72.78% · α vs SPY +69.05% · entry $96.65 → $166.99
Entry anchored
Jun 24, 03:59 PM ET
via exchange tick
T+1d
+3.30%
call +3.30% · α +4.02%
$99.84
settled 3mo ago
T+5d
+5.79%
call +5.79% · α +4.23%
$102.25
settled 3mo ago
T+20d
-4.36%
call -4.36% · α -4.88%
$92.44
settled 2mo ago
T+60d
+72.78%
call +72.78% · α +69.05%
$166.99
settled 14d ago

Price Chart

Loading chart...

Executive Summary

Three Twist Bioscience insiders, including CEO Emily Leproust, sold a combined $203K in open-market transactions on June 22, 2026. The total value represents only ~0.004% of the company's $5.7B market cap, making this cluster immaterial and routine. No bearish signal is warranted given the trivial dollar amounts.

Key Financial Metrics

Direction
selling
Total Value
$203.0K
Insiders
3

Key Facts

  • CEO Emily Leproust sold 1,688 shares at $87.32 for $147K
  • SVP of HR Paula Green sold 291 shares at $87.32 for $25K
  • Executive Dennis Cho sold 346 shares at $87.32 for $30K
  • Total cluster value of $203K is ~0.004% of $5.7B market cap
  • All three sales occurred on the same day, suggesting a common liquidity or plan-driven event

Financial Impact

Trivial — $203K total sales, less than 0.01% of market cap

dilution

Risk Factors

  • Insider sales could precede a broader sell-off if they accelerate in size or frequency
  • Lack of insider buying alongside sales may indicate management is not aggressively bullish

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Biotech & Drug DiscoveryGenomics & Gene Editing

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1782370790505
27 reports for TWST
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+60▲ +52.11%May 4, 2026
Filters
Rows
Reports for TWST — sortable, filterable
TypeNow
Sep 10, 2026
21d ago
Insider Cluster
NEUTRAL ★ 2/10
$127.22 $166.99▲ +31.26%▲ +31.60%$187.45 (+47.34%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$153.10 $128.71▼ −15.93%▼ −16.20%$187.45 (+22.44%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$151.42 $132.06▼ −12.79%▼ −12.25%$187.45 (+23.79%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$145.59 $141.38▼ −2.89%▼ −3.37%$187.45 (+28.75%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$136.23 $153.10▲ +12.38%▲ +11.27%$187.45 (+37.60%)
Aug 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$124.41 $140.80▲ +13.17%▲ +14.36%$187.45 (+50.67%)
Aug 14, 2026
6w ago
Insider Cluster
BEARISH ★ 6/10
$124.41 $140.80▼ −13.17%▼ −14.36%$187.45 (−50.67%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$125.29 $136.23▲ +8.73%▲ +10.70%$187.45 (+49.61%)
Aug 12, 2026
7w ago
144
NEUTRAL ★ 2/10
$125.29 $136.23▲ +8.73%▲ +10.70%$187.45 (+49.61%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$123.12 $116.10▼ −5.70%▼ −5.30%$187.45 (+52.25%)
Showing 10 of 27

US Market Status

Market Open — Closes in 3h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 25, 2026